Nanosphere Raises $35.3M in Public Offering | GenomeWeb

NEW YORK (GenomeWeb News) – Nanosphere has closed a public offering of its common stock, raising approximately $35.3 million.

The Northbrook, Ill.-based molecular diagnostics firm sold 5,405,000 shares of common stock at a price of $7 per share. The total number of shares sold includes 705,000 shares that comprised the over-allotment option.

Nanosphere said that it will use the proceeds for general corporate purposes and working capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.